Leaderboard

En | De
Sie sind hier: Dermatologie » Psoriasis 29. April 2026
Suchen
medline.ch
Psoriasis
Erweiterte Suche
Dermatologie
Akne
Alopezie
Dermatitis
Infektionen
Photosensitive Erkrankungen
Psoriasis
Tumoren
Ulcus
Urtikaria
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1391  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 27816  
   
Comparative Efficacy and Safety of Topical Clobetasol Propionate 0.05% Ointment Versus Topical Methotrexate 1% Gel in Limited Plaque Psoriasis: A Prospective Open-Label Study.
Cureus
Thakur R, Asati DP, Verma K, Sharma S, Budhwani V.
PMID: 42051836 [PubMed]


Long-Term Particulate Matter Exposure and Risk of Psoriasis Incidence, and Short-Term Exposure and Risk of Exacerbation: A Nationwide Cohort Study.
J Dermatol
Kim BR, Nam J, Lee J, Kang S, Kang SW, Kim M, Cho J, Kang D, Youn SW.
PMID: 42050799 [PubMed - as supplied by publisher]


NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis.
JCI Insight
Han K, Klein RJ, Recupero TC, Russo AC, Sharma R, Gupta AK, Hassanzadeh S, Huffstutler RD, Dagur PK, Fisk B, Redekar NR, Sack MN.
PMID: 42048163 [PubMed - as supplied by publisher]


Isolated nail psoriasis: diagnostic challenges and therapeutic advances.
Ital J Dermatol Venerol
Chalupczak NV, Lipner SR.
PMID: 42047681 [PubMed - as supplied by publisher]


Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis.
NEJM Evid
Smieszek S, Przychodzen B, Tyner C, Johnson C, Bushman M, Brzezynski J, Reich A, Bachelez H, Yap EWY, Borlu M, Chaowattanapanit S, Denguezli M, Gudjonsson JE, Lizzul P, Dahl M, Parmley S, Randazzo B, Severtson A, Raina P, Saikali K, Xiao C, Polymeropoulos C, Birznieks G, Polymeropoulos M.
PMID: 42047557 [PubMed - indexed for MEDLINE]


Transcriptomic meta-analysis identifies core molecular pathways in plaque psoriasis.
J Eur Acad Dermatol Venereol
Torres-Moral T, Riera-Monroig J, Tell-Martí G, Gómez-Cabañes B, Bagué J, Català-Senent JF, Roig FJ, Potrony M, García-García F, Puig S.
PMID: 42047484 [PubMed - as supplied by publisher]


The Association Between SARS-CoV-2 Exposure, COVID-19 Vaccination and Psoriatic Arthritis-A Nested Case-Control Study.
Vaccines (Basel)
Haddad A, Zabari Parnis E, Stein N, Gazitt T, Saliba W, Zisman D.
PMID: 42042765 [PubMed]


Out-of-Pocket Expenses in Patients with Psoriasis: A Study from a Tertiary Care Hospital in North India.
Indian Dermatol Online J
Bhandari A, Narang S, Narang T, Kavita, Handa S, Dogra S, Prinja S.
PMID: 42041242 [PubMed - as supplied by publisher]


Immunoregulation by DC and T cells in psoriasis with probable immunotherapeutic approaches.
Int Rev Immunol
Kundu S, Paul R, Chakraborty K.
PMID: 42041098 [PubMed - as supplied by publisher]


Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis : Molecular Pathogenesis of Psoriasis.
Galen Med J
Shokoufa P, Aghaei M.
PMID: 42038851 [PubMed]


Comments on Chiu et al.'s " Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: A 15-year multicenter cohort study".
J Am Acad Dermatol
Xiao Y, Li S, Cao X.
PMID: 42036024 [PubMed - as supplied by publisher]


Response to Bar et al.'s "Cancer progression, recurrence, and infection outcomes in psoriasis patients with active or recent malignancy treated with biologic therapy: A cohort study showing comparable safety to conventional agents".
J Am Acad Dermatol
Chen B, Yang L, Wang J, Hu T.
PMID: 42036022 [PubMed - as supplied by publisher]


Deucravacitinib in Moderate-to-Severe Plaque Psoriasis: A Real-World Study of Effectiveness and Safety in Clinical Practice.
Clin Exp Dermatol
Ruggiero A, Mozzillo R, Cordedda M, Camela E, Zanchini R, Colasanti P, Zagaria O.
PMID: 42035362 [PubMed - as supplied by publisher]


Reframing molecular superiority in the differential diagnosis of eczema and psoriasis.
J Eur Acad Dermatol Venereol
Sun M, Zang D, Chen J.
PMID: 42033216 [PubMed - as supplied by publisher]


Granulomatous prostatitis masquerading as suspected prostate cancer in a young patient on immunotherapy for psoriasis.
BMJ Case Rep
Guduguntla A, Ryan A, Sim K, Satasivam P.
PMID: 42031391 [PubMed - indexed for MEDLINE]


Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
Dermatol Ther (Heidelb)
Facheris P, Piscazzi F, Fiorillo G, Valenti M, Costanzo A, Borroni RG.
PMID: 42029886 [PubMed - as supplied by publisher]


3D-Printed lesion-conformal light-guiding patches for precise and personalized psoriasis phototherapy.
Biomater Sci
Wang Y, Mei L, Wan T, Fu Y, Xue X, Guo W, Wang Y, Zhao Y, Liu R.
PMID: 42029092 [PubMed - as supplied by publisher]


Prevalence and risk factors of fatty liver disease in psoriasis: A systematic review and meta-analysis based on NAFLD/MAFLD diagnostic criteria.
JAAD Int
Shen J, Liu L, Wang J, Cai X, Zhang M, Wang Q, Li X, Sun X.
PMID: 42027986 [PubMed]


A Study on Early Screening and Disease Characteristics of Psoriatic Arthritis Based on PEST Questionnaire and Musculoskeletal Ultrasound.
J Inflamm Res
Wei J, Guo Y, Ma J, Luo S, Li Y, Zhou Q, Tong X, Wang Z, Wang H.
PMID: 42027255 [PubMed]


Diagnosis and therapeutic management of psoriatic arthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA).
Ther Adv Musculoskelet Dis
Ramírez J, López-Medina C, Montilla C, Moreno M, Moreno MJ, Navarro V, Díaz D, Fernández-Clotet A, Riera-Monroig J, Díaz-Del Campo P, Cañete JD, Queiro R.
PMID: 42027204 [PubMed]


   
   Artikel 1 - 20 / 27816    Seite 1 von 1391  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1